Step 1 topics → Endocrine → Pheochromocytoma and Paraganglioma

Pheochromocytoma and Paraganglioma

USMLE Step 1 trap: Reverses the required sequence of alpha-then-beta blockade in pheochromocytoma preoperative management. Alpha-blockade (phenoxybenzamine or doxazosin) must be established before beta-blockade; starting beta-blockers first causes unopposed alpha-mediated vasoconstriction and can precipitate hypertensive crisis.

Pheochromocytoma is a catecholamine-secreting tumor of the adrenal medulla (chromaffin cells), and USMLE Step 1 tests it from multiple angles — but students consistently get the preoperative management sequence backwards, starting beta-blockade before alpha-blockade and risking a hypertensive crisis from unopposed alpha-mediated vasoconstriction. The exam presents patients with episodic hypertension, headache, diaphoresis, and palpitations, then asks you to identify the diagnosis, next workup step, or preoperative protocol. It also places pheochromocytoma in MEN2A, MEN2B, von Hippel-Lindau, and NF1 vignettes, so expect syndrome-based questions too.

What makes pheo genuinely tricky is that the exam deliberately tests whether you know the ORDER of things, not just the things themselves. Students often know that alpha and beta blockade are both used preoperatively, but get the sequence backwards. Starting beta-blockade first — or giving them simultaneously — can cause unopposed alpha-adrenergic vasoconstriction and trigger a hypertensive crisis. The exam exploits this by presenting a question where beta-blockade is offered as a reasonable or even first-listed option. Similarly, students default to checking serum catecholamines, which sounds logical but is actually inferior to plasma free metanephrines or 24-hour urinary fractionated metanephrines.

The rule of 10s is a high-yield organizational framework that USMLE Step 1 tests both as direct recall and embedded in vignette details (bilateral tumor, family history, extra-adrenal location). The most conceptually important rule: malignancy is NOT defined by histology. It is defined by metastasis to non-chromaffin tissue. A question that shows you 'concerning histologic features' and asks if the tumor is malignant is testing whether you fall for this trap.

From real student decks
76%have cards covering this topic
46%have mature cards

Common misconceptions

Common mistake
Wrong: Beta-blockade can be started first or simultaneously with alpha-blockade before pheo surgery.
Right: Alpha-blockade (phenoxybenzamine or doxazosin) must be established before beta-blockade; starting beta-blockers first causes unopposed alpha-mediated vasoconstriction and can precipitate hypertensive crisis.
Beta-blockers block β2-mediated vasodilation, so if you give them before alpha-blockade, all the circulating catecholamines from the tumor drive unopposed α1-mediated vasoconstriction — blood pressure spikes dangerously. You must first use phenoxybenzamine (irreversible, non-selective alpha blocker) or doxazosin to blunt that vasoconstriction, then add a beta-blocker to control reflex tachycardia. Think of it as: you can't close the beta door before the alpha door is already shut.
Common mistake
Wrong: Serum catecholamines are the preferred initial biochemical test for pheochromocytoma.
Right: Plasma free metanephrines or 24-hour urinary fractionated metanephrines are the preferred initial tests due to superior sensitivity compared to serum catecholamines.
Serum catecholamines are released episodically, so a random blood draw often catches normal levels even in a patient with a pheo — sensitivity is poor. Metanephrines are the stable metabolites produced continuously by the tumor's intracellular MAO activity, so they accumulate regardless of whether the patient is having a paroxysm at the time of testing. Plasma free metanephrines and 24-hour urinary fractionated metanephrines are therefore the gold-standard initial tests because they don't depend on catching the patient mid-episode.
Common mistake
Wrong: Malignancy in pheochromocytoma can be determined by histology alone.
Right: Malignancy in pheochromocytoma is defined by the presence of metastases to non-chromaffin tissue, not by histologic features; the rule of 10s states 10% are malignant.
Pheochromocytoma cells look similar under the microscope whether they're benign or malignant — there is no reliable histologic marker that predicts metastatic behavior. The only way to call a pheo malignant is to demonstrate spread to sites that don't normally contain chromaffin tissue, such as lymph nodes, liver, lung, or bone. This is a deliberate exam trap: if a vignette shows 'pleomorphic cells' or 'increased mitoses' and asks whether the tumor is malignant, the answer requires evidence of metastasis, not just the histology.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the classic paroxysmal triad (hypertension, headache, diaphoresis, palpitations) as the hallmark presentation of pheochromocytoma, and know that these symptoms arise from episodic catecholamine release from a chromaffin cell tumor of the adrenal medulla.
  2. Apply the rule of 10s to categorize pheochromocytoma features: 10% bilateral, 10% extra-adrenal (paraganglioma), 10% malignant, 10% in children, 10% familial — and know that malignancy is defined by metastasis to non-chromaffin tissue, not histology.
  3. Select the correct initial biochemical test for suspected pheochromocytoma: plasma free metanephrines or 24-hour urinary fractionated metanephrines are preferred over serum catecholamines due to higher sensitivity.
  4. Correctly sequence preoperative management: alpha-blockade (phenoxybenzamine or doxazosin) must be established first, followed by beta-blockade; reversing this order causes unopposed alpha-mediated vasoconstriction and hypertensive crisis.

Can you avoid these mistakes?

A 38-year-old woman presents with episodic severe headaches, profuse sweating, and blood pressure readings up to 210/120 mmHg. You suspect pheochromocytoma. What is the most appropriate initial biochemical test, and why is serum catecholamine measurement not preferred?
A patient with confirmed pheochromocytoma is scheduled for adrenalectomy. The intern starts propranolol to control the patient's heart rate of 105 bpm. What error has been made, and what is the expected consequence if alpha-blockade has not yet been established?
Pathology returns on a surgically resected adrenal mass showing chromaffin cells with 'marked nuclear pleomorphism and increased mitotic figures.' The surgeon asks if this tumor is malignant. What is the correct answer and reasoning?
A patient is found to have a pheochromocytoma on the right side. Genetic testing reveals a RET proto-oncogene mutation. What syndrome is this, and what other tumors must be screened for? Also, using the rule of 10s, what percentage of pheos are familial and what percentage are bilateral?

Related topics

Hypothalamic-Pituitary-Adrenal (HPA) Axis Hypothalamic-Pituitary-Thyroid (HPT) Axis Hypothalamic-Pituitary-Gonadal (HPG) Axis Hormone Signaling (Peptide vs Steroid)

See how your Anki deck covers this topic.

Upload your deck for a free audit →